Maria Lattanzio

Title: Maria Lattanzio: Innovator in Antitumor Research

Introduction

Maria Lattanzio is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds with antitumor activity. With a total of three patents to her name, Lattanzio is recognized for her innovative approaches to cancer treatment.

Latest Patents

Lattanzio's latest patents include groundbreaking work on selective HDAC6 inhibitors. This invention relates to novel benzohydroxamic compounds that exhibit high selective inhibitory activity against the histone deacetylase 6 (HDAC6) enzyme. Another notable patent involves benzo-N-hydroxy amide compounds that demonstrate significant inhibitory activity on the proliferation of tumor cells, specifically targeting cancer stem cells. These advancements highlight her commitment to addressing critical challenges in cancer therapy.

Career Highlights

Throughout her career, Maria Lattanzio has been associated with Italfarmaco Spa, a company dedicated to pharmaceutical innovation. Her work has not only contributed to the company's portfolio but has also advanced the scientific community's understanding of cancer treatment options.

Collaborations

Lattanzio collaborates with esteemed colleagues, including Barbara Vergani and Gianluca Fossati. These partnerships enhance the research environment and foster innovative solutions in the field of oncology.

Conclusion

Maria Lattanzio's contributions to pharmaceutical research, particularly in antitumor compounds, underscore her role as a leading inventor in the industry. Her patents reflect a dedication to improving cancer treatment and advancing medical science.